FDA approves splice-modulating drug.
Asher
A
Mullard
D017326:Clinical Trials, Phase III as Topic; D017277:Drug Approval; D015507:Drugs, Investigational / Q000627:therapeutic use*; D020868:Gene Silencing / Q000187:drug effects*; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D015507:Drugs, Investigational